4P-Pharma
Entity

  • 4P-Pharma

    Created in 2014
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    2,659

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    1 Rue du Professeur Calmette, 59800 Lille, France

    Lille

    France

  • Employees

    Scale: 11-50

    Estimated: 30

  • SIREN

    804204071

  • Engaged corporates

    6
    2 4

  • Added in Motherbase

    4 years, 11 months ago
Description
  • Value proposition

    Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly.​

    Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty.​

    We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible.

    Translational research, Biotechnology, Pharmaceuticals, Inflammation, Abuse deterrent formulations, Research and Development, Drug Development, Preclinical development, Clinical development, Partnerships, Osteoarthritis, Covid-19, Age-related diseases, and Respiratory Infectious diseases

  • Original language

    4P-Pharma est une société de biotechnologie lilloise au stade clinique fondée en 2014, qui se consacre à la régénération active de médicament dans l’objectif de développer des thérapies curatives pour des maladies graves non traitées.

    Notre démarche se différencie du développement pharmaceutique traditionnel par une approche de développement circulaire innovante, qui réduit le temps, les coûts et les risques, afin d’apporter des solutions thérapeutiques innovantes le plus rapidement possible aux patients. 4P-Pharma exploite des candidats médicaments dont le temps de développement est réduit notamment grâce à des opportunités règlementaires (« emergency use » ou autorisation conditionnelle de mise sur le marché) avec une forte propriété intellectuelle. 4P-Pharma se positionne ainsi dans des « blue-ocean markets ».

  • 4P Pharma, Translating Science to Medicine for Patients

    @4P Pharma is an R&D partner of academic and private institutions as well as life science investors. Our model is based on a co-risk co-share model.

    • https://4p-pharma.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Greater Paris University Hospitals - AP-HP
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care 		Not capitalistic
Partnership
Not event

20 Dec 2022


Le Figaro
Le Figaro
Media, Newspaper Publishing
Le Figaro
Media, Newspaper Publishing 		Other

16 May 2023


Europe 1
Europe 1
Broadcast Media Production and Distribution
Europe 1
Broadcast Media Production and Distribution 		Other

3 Jul 2023


LUTECH
LUTECH
LUTECH
Other

6 Apr 2024


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research 		Not capitalistic
Not partnership
Event

19 Apr 2024


BFM Business
BFM Business
Media, Broadcast Media Production and Distribution
BFM Business
Media, Broadcast Media Production and Distribution 		Not capitalistic
Not partnership
Event

29 Apr 2024


Similar entities
Last news
Show all articles
Social network dynamics